Circulating Adhesion Molecules in Obstructive Sleep Apnea and Cardiovascular Disease

Overview

Journal Sleep Med Rev

Date 2013 Apr 27

PMID 23618532

Citations 20

Authors

Victoria M Pak

Michael A Grandner

Allan I Pack

Affiliations

Soon will be listed here.

Abstract

Over 20 years of evidence indicates a strong association between obstructive sleep apnea (OSA) and cardiovascular disease. Although inflammatory processes have been heavily implicated as an important link between the two, the mechanism for this has not been conclusively established. Atherosclerosis may be one of the mechanisms linking OSA to cardiovascular morbidity. This review addresses the role of circulating adhesion molecules in patients with OSA, and how these may be part of the link between cardiovascular disease and OSA. There is evidence for the role of adhesion molecules in cardiovascular disease risk. Some studies, albeit with small sample sizes, also show higher levels of adhesion molecules in patients with OSA compared to controls. There are also studies that show that levels of adhesion molecules diminish with continuous positive airway pressure therapy. Limitations of these studies include small sample sizes, cross-sectional sampling, and inconsistent control for confounding variables known to influence adhesion molecule levels. There are potential novel therapies to reduce circulating adhesion molecules in patients with OSA to diminish cardiovascular disease. Understanding the role of cell adhesion molecules generated in OSA will help elucidate one mechanistic link to cardiovascular disease in patients with OSA.

Citing Articles

Role of exercise in reducing the risk of cardiovascular diseases associated with sleep disorders.

Qiao Y, Zhang P Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024; 49(4):526-533.

PMID: 39019781 PMC: 11255196. DOI: 10.11817/j.issn.1672-7347.2024.230426.

Increased Levels of VCAM-1 in Patients with High Cardiovascular Risk and Obstructive Sleep Apnea Syndrome.

Chetan I, Vesa S, Domokos Gergely B, Beyer R, Tomoaia R, Cabau G Biomedicines. 2024; 12(1).

PMID: 38255155 PMC: 10813101. DOI: 10.3390/biomedicines12010048.

Multisite and multitimepoint proteomics reveal that patent foramen ovale closure improves migraine and epilepsy by reducing right-to-left shunt-induced hypoxia.

Dong B, Lu Y, He S, Li B, Li Y, Lai Q MedComm (2020). 2023; 4(4):e334.

PMID: 37576864 PMC: 10422075. DOI: 10.1002/mco2.334.

Right ventricular responses to CPAP therapy in obstructive sleep apnea: CMR analysis of the MOSAIC randomized trial.

Samaranayake C, Turnbull C, Neubauer S, Kylintireas I, Stradling J, Craig S Pulm Circ. 2023; 13(1):e12201.

PMID: 36814585 PMC: 9939623. DOI: 10.1002/pul2.12201.

Correlation of Dyslipidemia and Inflammation With Obstructive Sleep Apnea Severity.

Popadic V, Brajkovic M, Klasnja S, Milic N, Rajovic N, Lisulov D Front Pharmacol. 2022; 13:897279.

PMID: 35694268 PMC: 9179947. DOI: 10.3389/fphar.2022.897279.

References

Bradley T, Floras J . Obstructive sleep apnoea and its cardiovascular consequences. Lancet. 2008; 373(9657):82-93. DOI: 10.1016/S0140-6736(08)61622-0. View

Demirseren M, Sarici M, Gokrem S, Yenidunya S . Protective effects of monoclonal antibody to intercellular adhesion molecule-1 in venous ischemia-reperfusion injury: experimental study in rats. J Reconstr Microsurg. 2007; 23(1):41-4. DOI: 10.1055/s-2006-958701. View

Spath-Schwalbe E, Gofferje M, Kern W, Born J, Fehm H . Sleep disruption alters nocturnal ACTH and cortisol secretory patterns. Biol Psychiatry. 1991; 29(6):575-84. DOI: 10.1016/0006-3223(91)90093-2. View

Ulukavak Ciftci T, Kokturk O, Bukan N, Bilgihan A . The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. Cytokine. 2004; 28(2):87-91. DOI: 10.1016/j.cyto.2004.07.003. View

Malik I, Danesh J, Whincup P, Bhatia V, Papacosta O, Walker M . Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis. Lancet. 2001; 358(9286):971-6. DOI: 10.1016/S0140-6736(01)06104-9. View

Kohli P, Balachandran J, Malhotra A . Obstructive sleep apnea and the risk for cardiovascular disease. Curr Atheroscler Rep. 2011; 13(2):138-46. PMC: 4332589. DOI: 10.1007/s11883-011-0161-8. View

Hajer G, van Haeften T, Visseren F . Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J. 2008; 29(24):2959-71. DOI: 10.1093/eurheartj/ehn387. View

Sajkov D, Cowie R, Thornton A, Espinoza H, McEvoy R . Pulmonary hypertension and hypoxemia in obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 1994; 149(2 Pt 1):416-22. DOI: 10.1164/ajrccm.149.2.8306039. View

Ursavas A, Karadag M, Rodoplu E, Yilmaztepe A, Oral H, Gozu R . Circulating ICAM-1 and VCAM-1 levels in patients with obstructive sleep apnea syndrome. Respiration. 2006; 74(5):525-32. DOI: 10.1159/000097770. View

10.

Grebe M, Eisele H, Weissmann N, Schaefer C, Tillmanns H, Seeger W . Antioxidant vitamin C improves endothelial function in obstructive sleep apnea. Am J Respir Crit Care Med. 2006; 173(8):897-901. DOI: 10.1164/rccm.200508-1223OC. View

11.

Cofta S, Wysocka E, Michalak S, Piorunek T, Batura-Gabryel H, Torlinski L . Endothelium-derived markers and antioxidant status in the blood of obstructive sleep apnea males. Eur J Med Res. 2010; 14 Suppl 4:49-52. PMC: 3521360. DOI: 10.1186/2047-783x-14-s4-49. View

12.

Lavie L, Vishnevsky A, Lavie P . Evidence for lipid peroxidation in obstructive sleep apnea. Sleep. 2004; 27(1):123-8. View

13.

Papayianni A, Alexopoulos E, Giamalis P, Gionanlis L, Belechri A, Koukoudis P . Circulating levels of ICAM-1, VCAM-1, and MCP-1 are increased in haemodialysis patients: association with inflammation, dyslipidaemia, and vascular events. Nephrol Dial Transplant. 2002; 17(3):435-41. DOI: 10.1093/ndt/17.3.435. View

14.

Shahar E, Whitney C, Redline S, Lee E, Newman A, Nieto F . Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med. 2001; 163(1):19-25. DOI: 10.1164/ajrccm.163.1.2001008. View

15.

Zarbock A, Kempf T, Wollert K, Vestweber D . Leukocyte integrin activation and deactivation: novel mechanisms of balancing inflammation. J Mol Med (Berl). 2011; 90(4):353-9. DOI: 10.1007/s00109-011-0835-2. View

16.

Hill J, Zalos G, Halcox J, Schenke W, Waclawiw M, Quyyumi A . Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 2003; 348(7):593-600. DOI: 10.1056/NEJMoa022287. View

17.

McNicholas W, Bonsigore M, Bonsignore M . Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J. 2007; 29(1):156-78. DOI: 10.1183/09031936.00027406. View

18.

Drager L, Bortolotto L, Lorenzi M, Figueiredo A, Krieger E, Lorenzi-Filho G . Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med. 2005; 172(5):613-8. DOI: 10.1164/rccm.200503-340OC. View

19.

Blake G, Ridker P . Inflammatory bio-markers and cardiovascular risk prediction. J Intern Med. 2002; 252(4):283-94. DOI: 10.1046/j.1365-2796.2002.01019.x. View

20.

Lavie L . Obstructive sleep apnoea syndrome--an oxidative stress disorder. Sleep Med Rev. 2003; 7(1):35-51. DOI: 10.1053/smrv.2002.0261. View